Ligelizumab

ligelizumab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Ligelizumab, covering 2022-12-30 to 2025-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Extension Study of Ligelizumab in Food Allergy [Phase 3]